These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 26338145)

  • 1. Prospects for broadly protective influenza vaccines.
    Treanor JJ
    Vaccine; 2015 Nov; 33 Suppl 4():D39-45. PubMed ID: 26338145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for Broadly Protective Influenza Vaccines.
    Treanor JJ
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S355-63. PubMed ID: 26590435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for universal influenza virus vaccine.
    Gerhard W; Mozdzanowska K; Zharikova D
    Emerg Infect Dis; 2006 Apr; 12(4):569-74. PubMed ID: 16704803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal influenza vaccine: the holy grail?
    Shaw AR
    Expert Rev Vaccines; 2012 Aug; 11(8):923-7. PubMed ID: 23002973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal influenza vaccines, science fiction or soon reality?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
    Rudraraju R; Mordant F; Subbarao K
    J Infect Dis; 2019 Apr; 219(Suppl_1):S81-S87. PubMed ID: 30715386
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in development of the influenza vaccine with broader cross-protection.
    Stropkovská A; Janulíková J; Varecková E
    Acta Virol; 2010; 54(1):7-19. PubMed ID: 20201609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 9. [The quadrivalent vaccines against seasonal influenza. Are the ultimate solution?].
    Reina J
    Med Clin (Barc); 2014 Apr; 142(8):355-7. PubMed ID: 24581840
    [No Abstract]   [Full Text] [Related]  

  • 10. Influenza vaccines and immunopathology.
    Gilbert SC
    Expert Rev Vaccines; 2012 Aug; 11(8):873-5. PubMed ID: 23002965
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza. Antigenic analysis of recent influenza virus isolates.
    Wkly Epidemiol Rec; 1993 Sep; 68(39):288. PubMed ID: 8217585
    [No Abstract]   [Full Text] [Related]  

  • 12. [The antigenic-immunogenic activity of the trivalent polymer-subunit influenza vaccine Grippol in a controlled epidemiological trial (2)].
    El'shina GA; Masalin IuM; Shervarli VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS
    Voen Med Zh; 1996 Nov; 317(11):53-5. PubMed ID: 9036633
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus.
    Zhang Y; Xu C; Zhang H; Liu GD; Xue C; Cao Y
    Viruses; 2019 Apr; 11(5):. PubMed ID: 31052339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHO announces flu vaccine formula for 1998-1999.
    Public Health Rep; 1998; 113(3):193. PubMed ID: 9633856
    [No Abstract]   [Full Text] [Related]  

  • 15. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa.
    Brokstad KA; Eriksson JC; Cox RJ; Tynning T; Olofsson J; Jonsson R; Davidsson A
    J Infect Dis; 2002 Apr; 185(7):878-84. PubMed ID: 11920311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine production: potential engineering approaches to pandemic influenza.
    Harding CV; Heuer AH
    J Pharm Sci; 2007 Nov; 96(11):2879-85. PubMed ID: 17721947
    [No Abstract]   [Full Text] [Related]  

  • 17. [Universal influenza vaccines: developments, prospects for use].
    Tsybalova LM; Kiselev OI
    Vopr Virusol; 2012; 57(1):9-14. PubMed ID: 22624467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Antigens for Universal Influenza Vaccine Development.
    Nguyen QT; Choi YK
    Viruses; 2021 May; 13(6):. PubMed ID: 34073996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine--outmaneuvering antigenic shift and drift.
    Treanor J
    N Engl J Med; 2004 Jan; 350(3):218-20. PubMed ID: 14724300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.